Αρχική Uncategorized High Jumper Training for Her Fifth Olympics Uses Personal Breast Cancer Story...

High Jumper Training for Her Fifth Olympics Uses Personal Breast Cancer Story to Encourage Screenings

The COVID-19 pandemic has led many people to put off routine health screenings due to fears of encountering the virus in public places, especially hospitals. One high jumper who’s training for her fifth Olympic Games is using her experience with breast cancer to encourage women to keep scheduling important health appointments.

36-year-old Chaunte Lowe initially found a very small lump in her breast during a self-examination when she was 34. The first doctor she saw said she shouldn’t be concerned and should get it checked in six years when she was 40.

When she noticed the lump had grown by last summer, she decided to go to another doctor to get a second opinion. The diagnosis was triple-negative breast cancer, an aggressive and fast-growing version of the disease. After she was diagnosed, Lowe had a double mastectomy and chemotherapy.

Lowe told Yahoo Sports, “I think back to the fact that if it were the middle of a pandemic, I don’t think I would have initially went back for that second appointment. That second appointment was so vital.”

Lowe is using her story as part of Cancer Screen Week, a partnership between the American Cancer Society, Genentech, Rally Health and Stand Up to Cancer. It got underway December 7th. Yahoo News says this year, screenings are falling through the cracks, with roughly two-thirds of Americans delaying them or skipping them.

Some people may also assume younger women wouldn’t have to worry so much about breast cancer.

Lowe told CNN, “I’m young, I’m healthy, I don’t drink, I’ve never drank, I don’t do drugs. I did all this stuff right to not have to be here. It was a misconception that leads to a lot of misdiagnoses early on, especially in young women.”

Thankfully, because Lowe pushed forward with her health screening, she’s now cancer-free and training for the 2021 Tokyo Olympics.

The COVID-19 pandemic’s postponement of the games has given Lowe a little more peace of mind. Her now compromised immune system would have caused her more stress if the Olympics had gone forward during the height of the pandemic.

Lowe said, “I would have been scared. And I would have had a lot of different worries going into it that maybe some of the other athletes didn’t have.”

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

In order to keep herself as safe as possible, she did have to stop training in public places. Her sponsors, however, helped her put a jumping pit in her backyard and install a weight room in her garage to keep her goal of a fifth Games going.

Throughout her cancer journey, Lowe has been committed to sharing her progress on social media to help others going through or recovering from a similar diagnosis. She hopes what she’s been through will inspire others.

She told Sports Illustrated, “I felt like I had to use my platform to make a difference. On a relay you run faster, because you’re running for your team. In this, I’m running for Team American Woman.”

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

Προηγούμενο άρθροSpirituality Resources
Επόμενο άρθροCould Cholesterol-Lowering Drugs Improve Cancer Immunotherapy?


Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...